General Fluidics Corporation
PrivateLast Round
Series B
Jul 16, 2024
Total Funding Raised
$34.84M
Company Overview
General Fluidics Corporation operates in Healthcare & Life Sciences and is based in Waltham, Massachusetts. Its latest recorded funding round was a Series B round in July 2024.
General Fluidics Corporation is a medical equipment and supplies manufacturing company that develops a novel, automated point-of-care diagnostic platform for clinical chemistry, hematology, and immunoassays.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
General Fluidics Corporation Comparables
Compare General Fluidics Corporation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Chengdu Seamaty Technology Co., Ltd. | 84% | |
| Soulbrain Holdings Co. Ltd | 79% | |
| Sight Diagnostics | 77% |
For institutional investors. Book with your work email.
General Fluidics Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 16, 2024 | ||||
| Debt | Jun 29, 2022 | ||||
| Series A | Dec 9, 2020 | ||||
| Seed | Sep 24, 2018 | ||||
| Grant | Sep 15, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
General Fluidics Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kendall Capital Partners | Debt, Series B |
| National Heart, Lung, and Blood Institute | Grant |
General Fluidics Corporation Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about General Fluidics Corporation's valuation, stock price, and market status.
Is General Fluidics Corporation a public or private company?
General Fluidics Corporation is a private company.
What is the current stock price of General Fluidics Corporation?
General Fluidics Corporation is a private company, so its shares have no public market price. Caplight tracks General Fluidics Corporation's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is General Fluidics Corporation worth (valuation)?
Valuation information for General Fluidics Corporation is not publicly available.
Can I buy General Fluidics Corporation stock?
General Fluidics Corporation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was General Fluidics Corporation's last funding round?
General Fluidics Corporation's most recent funding round was Series B on July 16, 2024.
Who are the main investors in General Fluidics Corporation?
Key investors in General Fluidics Corporation include Kendall Capital Partners, National Heart, Lung, and Blood Institute.
Will General Fluidics Corporation IPO soon?
No public IPO plans have been announced for General Fluidics Corporation.
How can I track General Fluidics Corporation secondary market activity?
Caplight tracks bids, offers, and trades in General Fluidics Corporation's shares on secondary markets.